Volume Re-Inflects, 2026 Currency Flips to a Tailwind, and the Refranchising Journey Ends — Upgrading to Outperform
Key Takeaways
- The single most important number reversed: unit case volume turned positive (+1%) after Q2's -1%, exactly the re-inflection our July initiation named as the upgrade trigger. Organic revenue accelerated to +6% (from +5%), comparable EPS of $0.82 (+6% YoY) beat the ~$0.78 consensus by four cents, and revenue of $12.46B edged consensus. Two-year volume trends accelerated each month through the quarter, with a slow July/August giving way to a stronger September. The stock rose 4.1% on the print.
- The 2026 currency picture flipped. Management's early framing is that, at current rates and hedges, 2026 would carry a slight tailwind to both comparable revenue and comparable EPS, versus the ~5-point headwind that held 2025 reported EPS growth to just ~3%. That closes the currency-neutral-to-reported gap that was the core of our Hold thesis. With ~8% currency-neutral EPS growth and a fading FX drag, reported earnings can re-accelerate in 2026 without any change in the underlying business.
- The decade-long refranchising journey is essentially complete. The July sale of 40% of the company-owned Indian bottler to the Jubilant Bhartia Group and this morning's announcement that Coca-Cola Hellenic will acquire a controlling interest in Coca-Cola Beverages Africa (closing in 2026) are the last two large pieces of a strategy begun in 2015. Only small markets (Malaysia, Singapore) remain. The result is a structurally higher-margin, asset-light system: comparable operating margin expanded ~120bps to 31.9%, and management reaffirmed the multi-year path toward the mid-30s from 26.5% in 2017.
- The balance sheet and cash flow strengthened further: net debt leverage fell to 1.8x EBITDA (below the 2.0–2.5x target), full-year free cash flow ex-Fairlife was raised to at least $9.8B (from ~$9.5B), and a favorable 3M appellate decision improves the odds in the company's long-running IRS transfer-pricing dispute. The 18th consecutive quarter of value share gains, with share held or gained in every geographic segment, underscores the franchise's competitive durability.
- Rating: Upgrading to Outperform from Hold. Both halves of our July upgrade trigger fired in one quarter: volume turned positive and the 2026 FX setup flipped to a tailwind. Add the refranchising completion (a structural margin catalyst), a 1.8x balance sheet, and a stock that has lagged the S&P 500 year-to-date (+9.9% vs. +14.5%, and down over the trailing twelve months), and a quality compounder re-accelerating into a cleaner 2026 algorithm is an attractive 12-month setup. We upgrade to Outperform.
Results vs. Consensus
Q3 2025 Scorecard
| Metric | Q3 2025 Actual | Consensus / Prior | Beat/Miss | Magnitude |
|---|---|---|---|---|
| Net Revenue (reported) | $12.46B | ~$12.43B | Beat | +0.2%; +5% YoY |
| Organic Revenue Growth | +6% | ~+5% | Beat | Accelerated from Q2's +5% |
| Unit Case Volume | +1% | ~flat | Beat | Re-inflected from Q2's -1% |
| Price/Mix | +6% | ~+5% | Beat | ~4pts price + 2pts mix |
| Comparable Gross Margin | -~10bps | — | Slight decline | Mix/marketing step-up |
| Comparable Operating Margin | 31.9% | ~30.7% | Beat | +~120bps YoY |
| Comparable EPS | $0.82 | ~$0.78 | Beat | +$0.04 (+5.1%); +6% YoY |
| GAAP EPS | $0.86 | — | +30% YoY | Cycling prior-year charges |
| FCF ex-Fairlife (FY guide) | ≥$9.8B | ~$9.5B prior | Raised | +$0.3B |
Year-Over-Year Comparisons
| Metric | Q3 2025 | Q3 2024 | YoY Change |
|---|---|---|---|
| Net Revenue (reported) | $12.46B | ~$11.85B | +5% |
| Organic Revenue | — | — | +6% |
| Unit Case Volume | +1% | ~flat | Re-inflected |
| Comparable Operating Margin | 31.9% | ~30.7% | +~120bps |
| Comparable EPS | $0.82 | $0.77 | +6% |
| GAAP EPS | $0.86 | ~$0.66 | +30% |
Quarter-Over-Quarter Context
The sequential decline in comparable operating margin (34.7% in Q2 to 31.9% in Q3) is normal seasonality plus a deliberate step-up in second-half marketing, not a deterioration. Coca-Cola's Q2 is structurally its highest-margin quarter; the relevant comparison is the +120bps of YoY expansion, which continues the year-to-date margin-expansion trend. More important is the directional reversal in volume (-1% in Q2 to +1% in Q3) and the steady ~6% organic, which together mark the inflection from a price-only quarter to a balanced volume-and-price quarter.
Quality of Beat
Revenue: Organic revenue of +6% accelerated from Q2's +5% and again sat at the high end of the 4–6% algorithm, but the composition improved materially. Price/mix of +6% now decomposes into roughly four points of pricing and two points of favorable mix, with intense-inflationary-market pricing "largely abated." That is a healthier mix than Q2's roughly five-points-price/one-point-mix split, because it is less dependent on hyperinflation pass-through and more on portfolio premiumization and innovation, which contributed strongly to revenue across the first three quarters.
Margins: Comparable operating margin expanded ~120bps to 31.9% even as comparable gross margin slipped ~10bps, the spread reflecting disciplined operating-expense management, supply-chain efficiencies, and marketing productivity. Management was explicit that the year-to-date margin expansion is "driven by our continued productivity mindset," not a one-off, and that it is funding rather than constraining the step-up in growth investment.
EPS: Comparable EPS of $0.82 (+6%) absorbed a ~6-point currency headwind, higher net interest expense, and a higher effective tax rate (20.7%). The clean read remains the operating line: with currency-neutral EPS growth tracking ~8% for the year and the FX drag set to fade in 2026, the reported EPS growth rate is poised to converge upward toward the operating rate, the single most important earnings dynamic heading into next year.
Segment Performance
Geographic Operating Segments — Q3 2025
| Segment | Unit Case Vol | Revenue / Profit | Value Share | Assessment |
|---|---|---|---|---|
| North America | flat | Strong rev + profit | Gained | Improved sequentially 2nd straight Q; Diet Coke growing |
| Latin America | flat | Grew (CN OI) | Gained | Brazil/Colombia/Chile up; Mexico still soft |
| EMEA | Grew | Strong rev + profit | Held/gained | Europe vol down (tough comp); Africa/Eurasia grew |
| Asia Pacific | Declined | Grew rev + profit | Gained | India monsoon, China, ASEAN drag; organic +7% (mix-weighted) |
Coca-Cola gained or held value share in every geographic segment this quarter, and overall value share for the 18th consecutive quarter. The reported segment operating-income lines remain distorted by currency and the ongoing refranchising; the comparable currency-neutral framework is the cleaner read on underlying momentum.
North America — The Sequential Recovery Continues
North America volume was flat but improved sequentially for the second consecutive quarter, with strong revenue and profit growth and continued value-share gains. The brand story broadened beyond Coca-Cola Zero Sugar: Diet Coke posted strong volume growth, reaching a new generation of consumers through campaigns like "Know the Signs" and retro line extensions (Diet Coke with Cherry, and Lime returning nationwide in October). The system accelerated cold-drink equipment placement and won share of visible inventory.
"We delivered strong results. Despite ongoing differences in spending between income groups and slower traffic across channels, volume was flat and improved sequentially for the second consecutive quarter." — Henrique Braun, COO
Assessment: North America volume not yet positive is the one blemish on an otherwise clean recovery, but the two-quarter sequential improvement, broadening brand strength (Diet Coke turning), and value-share gains point to volume crossing into positive territory soon. The margin and profit strength here is the asset-light model working; the next step is converting recovering share into outright volume growth rather than relying on price.
Asia Pacific — The Mix-Weighting Optical Illusion
Asia Pacific volume declined across all operating units (India's monsoon, China's macro softness, ASEAN weakness), yet organic revenue grew 7% and the segment's reported price/mix looked unusually high. The CEO walked through why: the segment spans very-low-priced, high-volume emerging markets (India) and high-priced developed markets (Japan, Australia). When the low-priced markets underperform on volume, the segment mix shifts toward the high-priced markets, mechanically inflating reported price/mix, the inverse of the usual pattern.
"This is a mix effect problem or a weighting problem of the way the segment is constructed… we should look for Asia Pacific over time to drive volume growth in the emerging markets." — James Quincey, Chairman & CEO
Assessment: The Asia Pacific optics are a recurring source of confusion and should be looked at on a multi-quarter basis. The underlying truth is less flattering than the +7% organic suggests, the segment's volume engine (India) stumbled on weather, but it is also less concerning than a declining-volume headline implies, because the long-run India volume opportunity is intact. Treat this quarter's Asia print as noise around a positive multi-year trend.
Latin America — Mexico Still the Swing Factor
Latin America volume was flat with value-share gains and currency-neutral operating-income growth. Brazil remained strong (Coca-Cola Zero Sugar gaining share through dual packs and the meals occasion), and Colombia and Chile grew, but Mexico, the region's anchor, is on a "progressive improvement" rather than a clean recovery, with macroeconomic pressure persisting. Santa Clara became the value-share leader in Mexican value-added dairy (+13% volume).
Assessment: Mexico is the segment's and arguably the company's most important near-term volume swing factor, and management was candid that it is "not yet where we want it to be." The looming Mexico sugar-tax increase (effective January 2026) adds a 2026 headwind. The offset is the company's proven 2014 playbook for absorbing such taxes through marketing, RGM, and execution, and the broad regional strength outside Mexico.
Key Topics & Management Commentary
Overall Management Tone: Confident and forward-leaning, a notable step up from Q2's more defensive "pivot" framing. With volume re-inflected and a new COO (Henrique Braun) presenting segment detail for the first time, the call balanced near-term execution confidence against honest acknowledgment of pockets of consumer pressure and a softer Mexico. The most consequential commentary was prospective: an unusually constructive set of 2026 considerations (currency tailwind, normalized pricing, balanced volume-and-price algorithm, completed refranchising) that reframes the forward earnings setup.
1. Volume Re-Inflection: The Algorithm Reasserts
Unit case volume turned positive (+1%) after Q2's decline, with two-year trends accelerating each month and a slow July/August giving way to a stronger September. Management was clear that the improvement was driven less by a changing environment than by its own interventions, increased marketing, sharper innovation, affordability and revenue-management actions with bottlers, and stepped-up execution.
"I don't think the environment changed markedly in September from July and August. We just got more focused on drilling down into what needed to be done… to driving the quarter." — James Quincey, Chairman & CEO
Assessment: This is the data point that resolves the central question of our July Hold thesis. Volume turning positive on the back of self-help (rather than a macro tailwind) is actually the more durable outcome, because it demonstrates the system can manufacture volume growth through execution even in a choppy environment. The caveat is the Q4 comparison is steeper, so the +1% is not yet a clean trend; but the direction, and the reason for it, are exactly what the bull case needed.
2. The 2026 Currency Flip: From Headwind to Tailwind
The most market-relevant disclosure was the CFO's early 2026 framing: at current rates and hedge positions, currency would be a slight tailwind to both comparable net revenues and comparable EPS in 2026, a reversal of the ~5-point EPS headwind that has held 2025 reported comparable EPS growth to ~3% against ~8% currency-neutral growth.
"Regarding currency, if we assume current rates and our hedge positions, there would be a slight tailwind to both comparable net revenues and comparable earnings per share for full year 2026." — John Murphy, President & CFO
Assessment: This is the second half of our upgrade trigger and arguably the most important sentence on the call for the stock. The entire gap between Coca-Cola's strong operating performance (~8% currency-neutral EPS) and its muted reported earnings (~3%) in 2025 is currency. If FX flips even to neutral, reported 2026 EPS growth converges toward the high single digits; a tailwind pushes it higher. Management hedged the claim appropriately (rates can move before February guidance), but the directional reversal materially de-risks the 2026 reported-earnings setup.
3. Refranchising Complete: The 10-Year Journey Ends
Management announced the two final large pieces of a refranchising strategy begun in 2015: the July sale of 40% of the company-owned Indian bottler to the Jubilant Bhartia Group, and Coca-Cola Hellenic's intent to acquire a controlling interest in Coca-Cola Beverages Africa (closing 2026). Only small markets (Malaysia, Singapore) remain. The strategic point is that placing bottlers with the right long-term owners drives more local investment, better execution, and faster, more profitable system growth.
"Those 2 transactions are the last 2 large pieces setting us on the path to completing the refranchising strategy that we started in 2015… think of it as this is the final piece of stone in putting refranchising strategy to bed." — James Quincey, Chairman & CEO
Assessment: This is a structural margin and returns catalyst that the market under-weights because it has been a slow ten-year grind. With the capital-intensive, low-margin bottling revenue exiting the consolidated P&L, the company is structurally lighter, higher-margin, and more focused on the high-return concentrate and brand-building business. It is the foundation of the mid-30s operating-margin path and a key support for the Outperform case.
4. The Margin Path: 26.5% to the Mid-30s
The CFO framed the margin trajectory explicitly: operating margin was 26.5% in 2017, and two forces have driven it higher since, refranchising (mix) and ongoing core-business expansion (productivity), partly offset by FX. Year-to-date, the core-expansion lever has been the primary driver, with supply-chain efficiency, cost discipline, and marketing productivity all contributing.
"In 2017, our operating margin was 26.5%… you can assume that the implied expansion that we expect from the core business will continue, and the math will play itself out in terms of the uplift in the overall margin profile… with the latest refranchising." — John Murphy, President & CFO
Assessment: Two independent, durable margin levers, refranchising mix and core productivity, give the margin expansion a multi-year runway rather than a single-year ceiling. This underpins our view that comparable operating margin can keep grinding higher even in years where volume is only modestly positive, and it is the mechanism by which mid-single-digit organic growth converts to high-single-digit-plus operating-income growth over time.
5. Fairlife: The 30% Capacity Unlock Arrives in 2026
Fairlife and Core Power continued to grow in Q3 while remaining on allocation to retailers. The CEO quantified the unlock for the first time: the new Upstate New York facility, one of the largest dairy processing plants in the US, adds roughly 30% capacity when fully ramped, and will progressively move Fairlife off allocation through 2026. The protein category remains squarely on trend, including as a beneficiary of GLP-1-driven dietary shifts.
"The New York factory, when at full capacity, will give us about 30% more capacity or volume potential for fairlife… that will help us get out of the… bottlenecks that we're in at the moment." — James Quincey, Chairman & CEO
Assessment: A 30% capacity addition to a brand currently rationing demand is a concrete, dated 2026 growth catalyst. The risk is competitive entry into high-protein dairy, but the multi-year brand and distribution lead is substantial, and the international optionality (templated on the 10x scaling of Santa Clara in Mexico) is real if early. Fairlife remains the most attractive discrete growth asset in the portfolio.
6. GLP-1: A Net Neutral-to-Positive for the Portfolio
Asked directly about GLP-1 weight-loss drugs and beverage consumption, the CEO shared the company's emerging data: households on GLP-1s drink less full-sugar soda but more diet soft drinks, more hydration, more coffee, and notably more protein drinks. This maps almost perfectly onto Coca-Cola's portfolio strengths, the Zero Sugar/Diet engine, water and sports hydration, coffee, and Fairlife.
"They tend to drink less full sugar soft drinks, but they tend to drink more diet soft drinks, also hydration, more coffee and… a big shift towards protein drinks." — James Quincey, Chairman & CEO
Assessment: This is the clearest management framing to date of why the GLP-1 overhang, a recurring bear talking point, is overstated for Coca-Cola specifically. The dietary shift GLP-1s induce flows toward categories where the company is already strong or accelerating. It is not a clean positive (full-sugar soda is still the largest profit pool), but the portfolio breadth makes Coca-Cola a relative winner rather than a victim of the trend.
7. "The Future Belongs to the Discontented": Productivity and 2026 Restructuring
Pressed on whether Coca-Cola would follow peers into formal restructuring, the CEO invoked a 90-year-old internal Woodruff speech ("the future belongs to the discontented") to frame a continuous-productivity philosophy, and confirmed the company will undertake some organizational restructuring in 2026, leveraging AI and agentic technology, to fund continued top-line investment.
"This is all about replicating the game plan over the last 10 years of finding productivity through the whole P&L to invest and drive top line growth that falls to the bottom line… we'll do some restructuring of the organization in… 2026." — James Quincey, Chairman & CEO
Assessment: The 2026 restructuring and AI/agentic productivity program is a fresh, identifiable margin lever layered on top of refranchising and core productivity. The framing, productivity as a permanent discipline funding growth rather than a one-off cost cut, is the right one for a quality compounder, and it adds a third leg to the multi-year margin-expansion thesis.
8. Free Cash Flow, Balance Sheet, and the IRS Dispute
Year-to-date free cash flow ex-Fairlife was $8.5B, up versus the prior year, and full-year guidance was raised to at least $9.8B. Net debt leverage fell to 1.8x EBITDA, below the 2.0–2.5x target range. The CFO also flagged a favorable development in the long-running IRS transfer-pricing dispute: a recent 3M appellate court decision on the same Brazilian-royalty regulation that the company views as "highly supportive" of its position.
Assessment: The cash-flow raise and 1.8x leverage reinforce the dividend-King thesis and leave ample capacity for buybacks and bolt-ons. The IRS matter, a multi-billion-dollar tail risk that has overhung the stock for years, is not resolved, but a supportive appellate precedent meaningfully improves the odds and reduces the probability-weighted liability. Both are incremental positives that firm up the downside.
Guidance & Outlook
| Metric | FY25 Guide (Updated) | 2026 Early Considerations |
|---|---|---|
| Organic Revenue Growth | 5–6% (reiterated) | Balanced 4–6%: ~2–3% volume + ~2–3% price |
| Comparable CN EPS Growth | ~8% (reiterated) | To be guided in February |
| Comparable EPS Growth (reported) | ~3% (vs. $2.88) | FX flips to slight tailwind — gap closes |
| Currency Impact (EPS) | ~-5 points | Slight tailwind at current rates |
| Underlying Tax Rate | 20.7% | To be guided in February |
| FCF ex-Fairlife | ≥$9.8B (raised) | — |
Management reiterated full-year 2025 guidance, organic revenue growth of 5–6% and comparable currency-neutral EPS growth of ~8%, while raising the free-cash-flow guide to at least $9.8B. The reported comparable EPS growth of ~3% versus $2.88 holds, still gated by the ~5-point 2025 currency headwind and the 20.7% tax rate.
The 2026 setup is the real news. Three early considerations reframe next year: (1) a calendar shift adding six days to Q1 and removing six from Q4, which will distort quarterly cadence but not the full year; (2) a balanced top-line algorithm explicitly targeting ~2–3% volume and ~2–3% price as inflation normalizes, the healthy "earn the right to price through volume" model; and (3) the currency flip to a slight tailwind. Together they describe a 2026 in which reported earnings growth can re-converge with the ~8% operating rate.
Implied trajectory: If 2026 delivers ~mid-single-digit organic growth with normalized pricing, continued margin expansion from refranchising plus core productivity plus the new restructuring program, and even a neutral-to-positive currency, reported comparable EPS growth could step up from ~3% in 2025 toward high-single-digits in 2026. That re-acceleration, off a depressed 2025 base, is the core of the upgrade.
Guidance style: Consistent with its conservative posture, management declined to put a number on 2026 (deferred to February) while sharing directional considerations. The Mexico sugar-tax increase (effective January 2026) and ongoing trade/commodity volatility are the acknowledged offsets; management characterized commodity inflation as "manageable."
Analyst Q&A Highlights
What Drove the September Acceleration, and What It Means for 2026 Planning
The opening question probed whether the late-quarter improvement reflected better underlying category trends or the company's own interventions, and how that read feeds 4Q and 2026 planning. Management attributed the acceleration squarely to self-help, marketing, innovation, affordability, and execution, rather than a changing environment, and laid out the 2026 balanced-algorithm framing for the first time.
Q: "It appears that you came out the quarter with seeing a bit more acceleration… I'm curious as to whether you would ascribe that to sequential improvement in underlying category trends or more your own interventions… and how those recent observations factor into both your fourth quarter views as well as your approach to the fiscal '26 planning."
— Steve Powers, Deutsche Bank
A: "As much as anything, that was a doubling down by the system… If our long-term growth model calls for 4% to 6% on the top line and we look for balance, which kind of implies 2% to 3% on volume and 2% to 3% on price… Our long-term objective remains to grow volume as a way of expanding our consumer franchise and earning the right to pricing."
— James Quincey, Chairman & CEO
Assessment: The most important exchange on the call for the forward thesis. Management is telling investors that 2026 returns to a balanced, higher-quality algorithm, volume doing roughly half the work, rather than the price-dependent 2025. That the September recovery came from execution rather than a macro tailwind makes the +1% volume more credible as a base for 2026's ~2–3% volume target.
The Path to the Mid-30s Operating Margin Post-Refranchising
A question on the just-announced CCBA deal asked what remains to refranchise and walked through the margin implications, given the company is approaching its prior mid-30s operating-margin aspiration. Management confirmed CCBA and India are the last two large pieces and the CFO laid out the two-lever margin bridge from 26.5% in 2017.
Q: "A few years ago, you had a target of like a mid-30s operating margin target… it seems like you're getting pretty close to that after this transaction. So can you walk us through the path on the margins post refranchising?"
— Filippo Falorni, Citi
A: "In 2017, our operating margin was 26.5%… the implied expansion that we expect from the core business will continue, and the math will play itself out in terms of the uplift in the overall margin profile of the company with the latest refranchising." — John Murphy, President & CFO
Assessment: Management effectively confirmed a multi-year margin-expansion runway from two independent levers (refranchising mix + core productivity), with the new 2026 restructuring program as a third. For modeling, this supports continued comparable operating-margin expansion through 2026–2027 even on modest volume, and it is the mechanism that converts mid-single-digit organic growth into faster operating-income and EPS growth.
Local and Regional Competition Under Consumer Pressure
A question asked where local or regional competition has intensified as affordability becomes a bigger consumer theme, and how the company is responding. The CEO reframed it as a broader "pendulum swing toward regionality," not purely an affordability phenomenon, and described pushing resources to the front line to enable differentiated local responses.
Q: "When consumers are under pressure, affordability becomes a discussion point, you'll start to see some bubbling up of local competition, particularly in sparkling… any markets where that's been a factor and then what you're doing in response?"
— Lauren Lieberman, Barclays
A: "There's a big overall shift to a little more localness… we're seeing that there's more dynamism in regional competitors… we're responding by driving more resources to the front line so that we can have different responses in different places."
— James Quincey, Chairman & CEO
Assessment: A measured answer that acknowledges a real competitive dynamic without overstating it. The "global scale plus local intimacy" framing is the right structural response, and the COO's emphasis on getting closer to the consumer suggests the organizational design is being tuned for it. We see this as a manageable, ongoing pressure rather than a thesis risk, but worth monitoring in affordability-sensitive emerging markets.
The Latin America and Mexico Consumer
A question sought a deeper read on Latin America, particularly Mexico and Brazil, and whether the softness is regional or country-specific. The new COO drew the distinction clearly: the region is broadly healthy (Brazil strong, Colombia and Chile growing), with Mexico the specific soft spot on domestic macro issues rather than a regional malaise.
Q: "I just want to dive a bit deeper into Latin America… what you're seeing on the ground in Mexico as well as Brazil… and just how that consumer environment might impact your forward performance."
— Dara Mohsenian, Morgan Stanley
A: "Brazil continues to be pretty strong. Colombia and Chile also grew… Mexico is also a big market, but it's on a progressive improvement, but not yet where we want it to be. There are macroeconomic issues in the country… it's more related to the country itself."
— Henrique Braun, COO
Assessment: Isolating the weakness to Mexico-specific macro (rather than a broader Latin American consumer break) is reassuring for the regional thesis, but Mexico is large enough, and now faces a January sugar-tax increase, to remain the most important single-country swing factor into 2026. The 2014 tax-absorption playbook is the relevant precedent and a source of confidence, but the near-term drag is real.
GLP-1 Drugs and the Protein Platform
A question revisited the GLP-1 debate with two years of additional data, asking what the company's own research shows about beverage consumption among GLP-1 users and for a capacity/competitive update on the protein platform. The CEO's data-grounded answer described a dietary shift that favors most of Coca-Cola's growth categories.
Q: "GLP-1 drugs… at this point, you ought to have some reasonably good data on their impact on beverage consumption… what your data says. Do you see those increases? Do you see areas where there's weakness?"
— Robert Ottenstein, Evercore ISI
A: "They tend to drink less full sugar soft drinks, but they tend to drink more diet soft drinks, also hydration, more coffee and… a big shift towards protein drinks… we've got fairlife and Core Power… the capacity… in Upstate New York is on track."
— James Quincey, Chairman & CEO
Assessment: The single best rebuttal to the long-running GLP-1 bear case, grounded in the company's own consumption tracking. The dietary shift moves spending toward Zero Sugar/Diet, hydration, coffee, and protein, all areas where Coca-Cola is strong or accelerating. This reframes GLP-1 from a structural demand threat to a portfolio-mix tailwind for a company with Coca-Cola's breadth, and it materially softens a key bear pillar.
Restructuring and the Productivity Philosophy
A question on the divergence between cautious bank/retailer commentary and more resilient CPG results asked where Coca-Cola stands, given many peers have restructured. The CEO used the question to confirm a 2026 restructuring leveraging AI and agentic technology, framed within a permanent-productivity philosophy.
Q: "Many of your CPGs have restructured… Obviously, there's no restructuring [for you]. There's a bit of productivity. But can you just maybe talk about the differences in what we're hearing versus what maybe we're seeing from your business?"
— Kaumil Gajrawala, Jefferies
A: "We will be discontented with ourselves… that will include ongoing productivity as we bring in AI and agentic tech over the coming years, and we'll do some restructuring of the organization in… 2026… to invest and drive top line growth that falls to the bottom line."
— James Quincey, Chairman & CEO
Assessment: The confirmation of a 2026 restructuring adds a concrete, fresh margin lever to the multi-year story, distinct from refranchising and core productivity. The framing, productivity as a permanent discipline that funds growth rather than a defensive cost cut, is exactly what an investor wants from a quality compounder, and the AI/agentic angle gives it durability into 2026–2027.
What They're NOT Saying
- A 2026 EPS number: Management shared rich directional 2026 color (currency tailwind, balanced algorithm, restructuring) but deferred any numeric guide to February. The directional signals are bullish, but the magnitude of the reported-EPS reacceleration remains unquantified.
- The size of the Mexico sugar-tax drag: Management confirmed the tax is "significant" and effective January 2026 and pointed to the 2014 playbook, but did not size the volume or earnings impact, leaving a known 2026 headwind unquantified against the otherwise constructive setup.
- North America volume turning positive: The segment improved sequentially for a second straight quarter but volume is still only "flat." Management did not commit to a timeline for North America volume crossing into positive territory, the developed-market proof point still pending.
- Costa's endgame: Coffee returned to volume growth, but management reiterated that the Costa investment hypothesis (non-retail/ready-to-drink scaling) has not worked and it is still "reflecting," with no decision, divestiture, or impairment framing offered.
- The CCBA deal's financial terms and margin step-up: The completion of refranchising was framed strategically, but the specific consolidated-margin uplift and timing from deconsolidating CCBA were left to "the math will play itself out," without a quantified bridge.
Market Reaction
- Pre-print setup: KO closed at $68.44 on October 20, up 9.9% year-to-date but trailing the S&P 500's +14.5%, and down 1.5% over the trailing twelve months, an underperforming defensive laggard entering the print. The stock sat mid-to-upper in its $60.81–$73.90 52-week closing range and was up 3.0% over the trailing 30 days.
- Reaction-day session (October 21, before-open report): KO gapped up 3.1% to open at $70.57, traded a $70.23–$71.39 range, and closed at $71.22, up 4.1% (+$2.78) on the day, the strongest single-session reaction in our coverage to date. Volume was 33.7M shares versus a 15.8M 30-day average (2.1x), a clear conviction move.
- Benchmark: The S&P 500 closed flat (0.0%) on the session, so KO outperformed the market by roughly four points on the print.
The 4.1% move on 2.1x volume is the market rewarding the volume re-inflection and the constructive 2026 framing, not a valuation re-rating from an extended base. Crucially, KO entered the print as a year-to-date laggard (trailing the S&P by ~460bps and down over the trailing year), so the rally came off a relatively de-rated starting point rather than a momentum peak. The combination, a positive fundamental surprise on a stock that had been left behind, is the most favorable kind of setup for a defensive name.
The reaction validates our read that the two swing factors we flagged in July, volume and the FX setup, were precisely what the market was waiting for. With both now turning, the stock cleared the "good but priced-in" reaction of Q2 and delivered the kind of decisive move that typically marks the start of a re-rating rather than its end.
Street Perspective
Debate: Is the 2026 FX Tailwind Real Enough to Underwrite an Earnings Re-Acceleration?
Bull view: The entire gap between Coca-Cola's ~8% currency-neutral EPS growth and its ~3% reported growth in 2025 is currency. Management has now signaled that, at current rates and hedges, 2026 FX flips to a slight tailwind. Off a depressed 2025 base, that mechanically re-accelerates reported EPS toward the high single digits with no change in the business, a clean, identifiable catalyst the market under-appreciates.
Bear view: Coca-Cola hedges much of its developed-market exposure, so any FX benefit is smoothed and delayed, and emerging-market currencies (the bigger structural drag) are volatile and largely unhedged. A "slight tailwind at current rates" in October is not guidance; rates can reverse before the February guide, and the company itself warned that many factors could change the outlook.
Our take: The bull case is more compelling because the direction of travel matters more than the precise magnitude. Even a neutral 2026 currency outcome (versus a -5-point 2025 drag) closes most of the reported-vs-operating gap. We would not underwrite a specific number ahead of February guidance, but the asymmetry has clearly shifted: the FX setup is now a tailwind risk to estimates rather than a headwind, which is the swing we were waiting for to upgrade.
Debate: Does Volume Re-Inflection Mark a Durable Algorithm Reset, or a One-Quarter Bounce?
Bull view: Volume turned positive on self-help (marketing, innovation, affordability, execution) rather than a macro tailwind, the more durable kind of recovery. Two-year trends accelerated each month, North America improved sequentially for a second straight quarter, and management explicitly targets ~2–3% volume in 2026. The franchise can manufacture volume growth through execution even in a choppy environment.
Bear view: A single +1% quarter after a -1% quarter is noise, not a trend, especially with Q4 cycling a steeper comparison that management itself flagged. Mexico is still soft and faces a January sugar tax, Asia Pacific volume declined, and North America volume is still only flat. The 2026 volume target is an aspiration, not a commitment.
Our take: The bull case is more persuasive on the why (execution-driven, broad-based sequential improvement, 18th straight quarter of share gains), while the bear case correctly flags Q4 comparison risk. We treat the +1% as a genuine inflection rather than a clean trend, and we will watch the Q4 print closely. The combination of positive volume and an improving mix (two points within price/mix) is enough to confirm the algorithm is reasserting, which is what the upgrade requires.
Debate: Is the Valuation Still a Constraint, or Has the Laggard Status Created Room?
Bull view: KO has lagged the S&P 500 year-to-date and is down over the trailing twelve months, so the defensive premium has partly de-rated in relative terms even as the fundamentals inflected. With volume turning, FX flipping, refranchising complete, and a 1.8x balance sheet, a re-accelerating compounder trading at a relative discount to a market up double digits is an attractive 12-month risk/reward.
Bear view: At roughly 24x forward earnings, KO is not cheap in absolute terms, and the +4% pop already captured much of the good news, leaving the stock near the top of its 52-week range. A risk-on tape that keeps favoring growth could continue to leave defensives behind regardless of fundamental improvement.
Our take: The laggard status is the key change from our July view. In July, KO had outperformed and we worried about a full multiple; in October, it has underperformed the market while its fundamentals improved, which is a materially better setup. The absolute multiple is still full, but on a relative basis and against an inflecting earnings trajectory, we see room for KO to outperform the S&P 500 over the next twelve months. That is the definition of our Outperform rating.
Model Update & Valuation
| Item | Prior (Q2 2025 Recap) | Updated (Q3 2025 Recap) | Reason |
|---|---|---|---|
| FY25 Organic Revenue Growth | 5–6% | 5–6% (high end) | Q3 organic +6%; volume re-inflected |
| FY25 Comparable CN EPS Growth | ~8% | ~8% | Reiterated |
| FY25 Comparable EPS (reported) | ~$2.97 (+3%) | ~$2.97 (+3%) | Unchanged; FX/tax gated |
| FY26 Comparable EPS Growth (reported) | n/a (not yet framed) | ~high-single-digit (preliminary) | FX flips to tailwind; ~8% CN + normalized algorithm |
| FY25 FCF ex-Fairlife | ~$9.5B | ≥$9.8B | Management raised |
| Net Leverage | 2.0x | 1.8x | Strong cash generation |
| Comparable Operating Margin Path | ~+150bps FY25 | Multi-year mid-30s path | Refranchising complete + core productivity + 2026 restructuring |
| 12-Month Fair-Value Range | $67–76 | $74–83 | ~24–26x ~$3.18 FY26 reported comparable EPS |
Valuation framework: At $71.22, KO trades at roughly 24x our ~$2.97 FY25 comparable EPS. The upgrade rests not on a cheaper multiple but on an inflecting earnings trajectory: with FX flipping to a tailwind, a balanced ~2–3% volume / ~2–3% price algorithm, and continued margin expansion, reported comparable EPS can re-accelerate from ~3% in 2025 toward high-single-digits in 2026 (we model ~$3.15–3.20). Holding a ~24–26x multiple on that re-accelerating base supports a 12-month fair-value range of $74–83, implying mid-single to mid-teens upside inclusive of the ~2.9% dividend.
Risk/reward: The downside is well-floored by the 1.8x balance sheet, the raised ~$9.8B+ FCF, the dividend, and the defensive demand profile (a ~$66–68 floor on any disappointment). The upside to the low-$80s is underwritten by the earnings re-acceleration and the relative-laggard starting point. With the catalysts (volume, FX) now turning rather than pending, the risk/reward has shifted favorably enough to justify Outperform.
Thesis Scorecard Post-Earnings
Scoring this quarter against the eight-pillar framework established at our July initiation:
| Thesis Point | Status | Notes (Q3 2025) |
|---|---|---|
| Bull #1 — All-weather pricing power & RGM: durable 5–6% organic | Strengthened | Organic accelerated to +6%; 18th straight quarter of value share gains; improved mix (2pts) |
| Bull #2 — Productivity + asset-light refranchised model lifts margins | Strengthened | Comparable OM +120bps; refranchising COMPLETE (CCBA + India); 2026 restructuring added |
| Bull #3 — Premiumization & portfolio (Zero Sugar, Fairlife) | Confirmed | Diet Coke turned positive; Fairlife +30% capacity in 2026; GLP-1 a net portfolio tailwind |
| Bull #4 — Fortress balance sheet & dividend-King returns | Strengthened | Leverage 1.8x; FCF guide raised to ≥$9.8B; IRS odds improve on 3M precedent |
| Bear #1 — Volume is the soft spot; algorithm leans entirely on price | Resolving | Volume re-inflected to +1%; mix improved; 2026 targets ~2–3% volume |
| Bear #2 — FX + higher tax cap reported earnings growth | Improving | 2026 FX flips to slight TAILWIND at current rates — closes the CN-to-reported gap |
| Bear #3 — EM macro volatility & health/GLP-1 overhang | Mixed | GLP-1 reframed as net positive; but Mexico soft + January sugar tax a new EM headwind |
| Bear #4 — Full defensive valuation limits multiple upside | Eased | Stock lagged S&P YTD; relative de-rating improves the entry despite full absolute multiple |
Overall: Thesis strengthened. All four bull pillars strengthened or confirmed; the two active bear pillars from July (volume, FX) are now resolving and improving respectively; the GLP-1 bear point reframed as a net positive. The only fresh negative is the Mexico sugar tax, a contained, country-specific 2026 headwind against an otherwise broadly improving picture.
Action: Upgrade to Outperform from Hold. Both swing factors we set in July turned this quarter. We would move back toward Hold if Q4 volume relapses negative and the 2026 FX tailwind evaporates before February guidance; we see no current path to Underperform given the balance-sheet strength and improving fundamentals.
Bottom Line: The Swing Factors Turned
Rating decision: We upgrade The Coca-Cola Company to Outperform from Hold. Our July Hold thesis was explicit about what would change our mind: a clean return to positive volume and an improving currency setup. Q3 delivered both in a single quarter, volume turned positive (+1%), organic accelerated to +6%, and management framed 2026 currency as a slight tailwind that closes the gap between the company's ~8% operating earnings growth and its ~3% reported growth. The decade-long refranchising journey ending, a 1.8x balance sheet, a raised free-cash-flow guide, and improving IRS-dispute odds are the supporting cast.
What gives us conviction to upgrade rather than merely confirm Hold: the change is structural, not cosmetic. Volume re-inflected on execution rather than a macro tailwind; the FX flip re-rates reported earnings without any change in the business; and refranchising completion plus the new 2026 restructuring program extend the margin-expansion runway. Set against a stock that has lagged the S&P 500 year-to-date and is down over the trailing year, a re-accelerating quality compounder is the right kind of 12-month bet.
What keeps us disciplined rather than euphoric: the +4% pop captured much of the immediate good news, North America volume is still only flat, Mexico faces a January sugar tax, and the 2026 currency claim is "at current rates" rather than guided. These keep us at Outperform rather than a higher-conviction stance, and they define what we are watching into Q4 and the February guide.
What would change our mind:
- Back to Hold: Q4 volume relapses negative on the steeper comparison, the 2026 FX tailwind evaporates before February guidance, or the Mexico sugar tax proves a larger 2026 drag than the 2014 playbook can absorb.
- Toward Underperform: a sustained organic-growth slip below the 4–6% algorithm combined with margin give-back, or a material adverse turn in the IRS dispute, neither of which is in evidence.
Signposts for Q4 / FY 2025 earnings (February 2026):
| Signpost | What to Watch | Bullish if… | Bearish if… |
|---|---|---|---|
| Unit case volume (Q4) | Hold positive despite tough comp | Volume stays positive; North America turns positive | Relapses negative on the steeper comparison |
| 2026 currency guide | February formal guide | Confirmed neutral-to-tailwind for 2026 | Reverts to a headwind on rate moves |
| 2026 EPS algorithm | Reported vs. CN convergence | Reported EPS guided to high-single-digits | FX/tax keep reported growth low |
| Mexico sugar tax | Volume/price absorption | 2014-style recovery plan in place | Material volume hit with limited offset |
| Margin expansion | FY25 comparable OM + 2026 path | Continued expansion + CCBA mix uplift visible | Margin give-back as reinvestment outpaces productivity |
| Fairlife capacity ramp | New York facility start | On-time start; off-allocation trajectory through 2026 | Start delayed; allocation persists |
| Refranchising / CCBA close | Deal progress + margin step | On-track to close 2026; quantified margin uplift | Regulatory delay |